Skip to main content

GENELUX Corp

GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001231457

In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding GENELUX Corp changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of GNLX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders7561−14
Shares7.30M7.39M+94.1K (+1.3%)
Value$19.7M$21.1M+$1.42M (+7.2%)

New holders (7)

Institutions that held GENELUX Corp at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to GNLX in Q2 2025
InstitutionSharesValue% of portfolio
Global Retirement Partners, LLC228,676$656.3K0.02%
Dauntless Investment Group, LLC123,194$263.3K1.24%
Flputnam Investment Management Co37,159$106.6K0.00%
Marshall Wace, LLP32,221$92.5K0.00%
Mariner, LLC30,030$86.2K0.00%
United Bank12,070$34.6K0.00%
Private Management Group Inc11,333$32.5K0.00%

Sold out (21)

Institutions that held GENELUX Corp at the end of Q1 2025 and filed for Q2 2025 without it.